Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations
- PMID: 7678900
- DOI: 10.1016/0027-5107(93)90115-v
Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations
Abstract
Somatic cell mutant frequencies at the hprt locus of the X-chromosome were measured with the T-lymphocyte cloning technique in healthy human populations. A statistical analysis was performed of assays from 232 individuals (77 males and 155 females) ranging in age from 19 to 80 years. Data from 4 donor groups were compiled: (a) 132 participants in a study of identical and fraternal twins; (b) 17 health care workers studied as part of an assessment of the risks of handling chemotherapeutic drugs; (c) 62 women with benign breast masses; and (d) 21 normal laboratory and office personnel. The relationship between age and mutant frequency (MF) was expressed by the equation: ln MF = 1.46 + 0.018 age (P < 0.001). Thus, MF increased by about 2% per year. Increases in cloning efficiency (CE) reduced the MF, as shown in the equation: ln MF = 2.91 - 1.32 CE (P < 0.001). CE was significantly related to age (CE = 0.47 - 0.002 age, P = 0.038), and the interdependent relationship between MF, age and CE expressed by the equation: ln MF = 1.99 - 1.13 CE + 0.016 age was significant at the P < 0.001 level. There was no statistically significant effect of donor gender or smoking history on MF in our population, but CE was significantly lower in males (P < 0.001). These findings confirm the importance of age and CE as factors which influence the thioguanine-resistant MF in circulating T-lymphocytes from normal adults.
Similar articles
-
Reduced proliferation rate of hypoxanthine-phosphoribosyl transferase mutant human T-lymphocytes in vitro.Environ Mol Mutagen. 1996;28(1):13-8. doi: 10.1002/(SICI)1098-2280(1996)28:1<13::AID-EM4>3.0.CO;2-F. Environ Mol Mutagen. 1996. PMID: 8698041
-
Hprt mutant frequency and GSTM1 genotype in non-smoking healthy individuals.Environ Mol Mutagen. 1995;25(2):97-105. doi: 10.1002/em.2850250203. Environ Mol Mutagen. 1995. PMID: 7698112
-
Impact of age and environment on somatic mutation at the hprt gene of T lymphocytes in humans.Mutat Res. 1995 Oct;338(1-6):129-39. doi: 10.1016/0921-8734(95)00018-2. Mutat Res. 1995. PMID: 7565868
-
Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age.Mutat Res. 1994 Jul 16;308(2):223-31. doi: 10.1016/0027-5107(94)90157-0. Mutat Res. 1994. PMID: 7518049
-
Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations.Mutat Res. 1991 Oct;253(2):199-213. doi: 10.1016/0165-1161(91)90133-s. Mutat Res. 1991. PMID: 1922146
Cited by
-
A review of HPRT and its emerging role in cancer.Med Oncol. 2018 May 5;35(6):89. doi: 10.1007/s12032-018-1144-1. Med Oncol. 2018. PMID: 29730818 Review.
-
Aging and the rise of somatic cancer-associated mutations in normal tissues.PLoS Genet. 2018 Jan 4;14(1):e1007108. doi: 10.1371/journal.pgen.1007108. eCollection 2018 Jan. PLoS Genet. 2018. PMID: 29300727 Free PMC article. Review.
-
Breast Cancer beyond the Age of Mutation.Gerontology. 2016;62(4):434-42. doi: 10.1159/000441030. Epub 2015 Nov 6. Gerontology. 2016. PMID: 26539838 Free PMC article.
-
Somatic mutations in aging, cancer and neurodegeneration.Mech Ageing Dev. 2012 Apr;133(4):118-26. doi: 10.1016/j.mad.2011.10.009. Epub 2011 Nov 3. Mech Ageing Dev. 2012. PMID: 22079405 Free PMC article. Review.
-
Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.Cancer Res. 2009 Sep 1;69(17):7004-12. doi: 10.1158/0008-5472.CAN-09-0451. Epub 2009 Aug 25. Cancer Res. 2009. PMID: 19706768 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous